InvestorsHub Logo
Followers 59
Posts 4696
Boards Moderated 0
Alias Born 04/27/2009

Re: None

Sunday, 06/26/2011 8:53:30 AM

Sunday, June 26, 2011 8:53:30 AM

Post# of 6247
Brendon Binneman, Pfizer
The monoclonal antibody, ponezumab, a phase 2 passive immunotherapy approach for Alzheimer’s disease

http://www-conference.slu.se/immunotherapyuppsala2011/programme.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PFE News